2024/07/01 20:08:18 | |
---|---|
Price | |
4.465 EUR | |
Difference | -1.65% (-0.08) |
ISIN | US67113Y6032 |
Symbol | CHFS |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 4.54 EUR |
High | 4.62 EUR |
Low | 4.11 EUR |
Close (prev. day) | 4.54 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/10/08 | Global Strategy 4Q 2024 | ||
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings |
2024/07/01 20:08:18 | |
---|---|
Price | |
4.465 EUR | |
Difference | -1.65% (-0.08) |
ISIN | US67113Y6032 |
Symbol | CHFS |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 4.54 EUR |
High | 4.62 EUR |
Low | 4.11 EUR |
Close (prev. day) | 4.54 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -76.38% | -94.81% | -99.96% |
Perf (abs.) | -14.44 | -81.64 | -12,245.54 |
Beta | -1.43 | -0.41 | 1.57 |
Volatility | 177.37 | 142.90 | 395.30 |
Ø price 5 days | Ø volume 5 days (pcs.) | 5.557 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 7.116 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 11.124 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 27.584 EUR (0) |
YTD High | date | 24.850 EUR (2024/02/27) |
YTD Low | date | 4.095 EUR (2024/06/27) |
52 Weeks High | date | 87.500 EUR (2023/07/26) |
52 Weeks Low | date | 4.095 EUR (2024/06/27) |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer